What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

New entity, ErnexaTX2, reflects progress toward clinical readinessCAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ernexa ...

Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 /PRNewswire/ -- Kimera Labs, Inc., the pioneer in therapeutic ...

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...

The approach also appears to be generally safe: The targeted liposomes showed no toxicity to human cells commonly affected during infection, including cells found in skin, blood vessels ...

People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may potentially allow people with type 2 diabetes to start producing more insulin ...